Xpeng Inc - ADR vs 22nd Century Group Inc — how do they compare? Xpeng Inc - ADR trades at $9.9 (market cap $9.16B), while 22nd Century Group Inc trades at $0.81 (market cap $621.67K). The key difference: Xpeng Inc - ADR is far larger — about 14734.5× 22nd Century Group Inc's market cap, and 22nd Century Group Inc is more actively traded (45,625 versus 5,030,325). Which is the better fit depends on your goals — on Pluang, investors hold Xpeng Inc - ADR for 80 Days and 22nd Century Group Inc for 32 Days on average.
| XPEV | XXII | |
|---|---|---|
Market Cap | $9.16B | $621.67K |
Volume | 5,030,325 | 45,625 |
Sector | Consumer Cyclical | Consumer Staples |
52-Week High | $28.07 | $483.00 |
52-Week Low | $9.25 | $0.80 |
Typical Hold Time | 80 Days | 32 Days |
Enterprise Value | $11.09B | -$3.69M |
Signals from Pluang's Aura AI — not financial advice
XPeng (XPEV) trades at $9.55, down 0.31% with a bearish technical signal. The company shows strong revenue growth to $76.72B in 2025 but remains unprofitable with a net margin of -4.14%. Recent vehicle deliveries of 41,256 in September 2026 and the upcoming G9L SUV launch at the Paris Motor Show highlight expansion efforts. Analyst consensus is bullish with a $17.55 price target, though earnings misses in Q1 and Q2 2026 raise execution concerns.
The stock presents a high-risk, high-reward opportunity. Significant revenue growth and analyst optimism are offset by persistent losses and competitive pressures. Key catalysts include successful global expansion and profitability improvements, while risks involve execution missteps and macroeconomic headwinds in the EV sector.
XXII trades at $0.8116, down 8.96% in the last session, with a bearish technical signal from moving averages. The company shows negative profitability metrics including -76.01% net income margin and -284.5% ROE, though valuation ratios appear low with P/S of 0.08 and P/B of 0.03. Recent news highlights regulatory progress in reduced-nicotine tobacco initiatives in France and Europe.
While analyst consensus is 75% buy with a $1,240 price target suggesting significant upside, fundamental challenges persist with consecutive earnings misses and negative cash flow from operations. The stock faces execution risk in commercializing its reduced-nicotine platform amid ongoing losses.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Founded in 2015, XPeng is a leading Chinese smart electric vehicle, or EV, company that designs, develops, manufactures and markets EVs in China. Its products primarily target the growing base of technology-savvy middle-class consumers in the midrange to high-end segment in China's passenger vehicle market. The company sold over 98,000 EVs in 2021, accounting for about 3% of China's passenger new energy vehicle market. It is also a leader in autonomous driving technology.
Read more on XPEV →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →